Skip to main content
. 2020 Jul 16;8:347. doi: 10.3389/fped.2020.00347

Table 4.

Follow-up data.

Patient# Age at D/C (months) FU time (months) LVEF at 1 month (%) LVEF at 3 months (%) LVEF at 6 months (%) LVEF at 12 months (%) BD (days post-PAB) BW
(kg, percentile)
Medications Ross class Final outcome
1 9.9 55.7 25 NA NA NA NA 8,
10th percentile
Immunosuppressant I ECMO → HT
2* 55 49.2 13 NA NA NA NA 12,
3rd percentile
Immunosuppressant I BH → HT°
3 5.7 37.5 24 19 30 56 566 13,
50th percentile
ASA, metoprolol, lisinopril I Recovery
4 13.7 30.2 32 27 22 19 149 and 233 11,
3rd−10th percentile
ASA lisinopril, bisoprolol, spironolactone, furosemide I Recovery
5 8.8 25.4 13 31 38 55 327 11,
10th−25th percentile
ASA, lisinopril, bisoprolol, spironolactone I Recovery

ASA, acetylsalicylic acid; BD, balloon dilation; BH, Berlin Heart; BW, body weight; D/C, discharge; ECMO, extracorporeal membrane oxygenation; FU, follow-up; HT, heart transplant; LVEF, left ventricular ejection fraction; NA, not applicable; PAB, pulmonary artery banding; OHT, orthotopic heart transplant.

the patient experienced infectious pneumonia at home 2 months after PAB (another hospital), followed by cardiogenic shock; he was transferred to other hospital, where ECMO, and successful OHT were performed.

°

owing to hemodynamic instability, the patient required implantation of Berlin Heart 33 days after PAB and subsequent successful OHT 13 months after PAB. He was weaned off from mechanical ventilation for the first time 14 days after Berlin Heart implantation.